Diseases · Entity Annotation Prototype (beta)

4articles mentioning diseases

9disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: CFTR ×

CFTR

This disease is selected. Its supporting articles are shown below.

CFTR4

Articles mentioning CFTR

4 articles · page 1 of 1

Predictive capacity of paediatric nasal epithelial cells in sequential CFTR modulator therapy

thoraxjnl · abstract · 2026-05-14 · 4 matching annotations

81.3%

cystic fibrosis CFTR CF CFTR modulators

…Background CFTR modulators have transformed cystic fibrosis (CF) treatment, but individual responses vary even among patien…

Pancreatic, nutritional and clinical outcomes in children 0–5 years with cystic fibrosis during the first 2 years of CFTR modulator therapy (PaNC): a multicentre prospective observational study protocol

bmjopen · abstract · 2025-07-30 · 3 matching annotations

87.5%

cystic fibrosis CF CFTR elexacaftor Monash Health Human Research Ethics Committee ivacaftor tezacaftor

… characterised by defects in the production and function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Ground-brea…

Evaluating the use and perceptions of cannabis and vaping post-cannabis legalisation in people with cystic fibrosis and CFTR-related disorder: survey results from a large Canadian adult cystic fibrosis clinic

bmjresp · abstract · 2025-12-25 · 1 matching annotations

79.3%

cystic fibrosis CF CFTR Cannabis Canadian adult CF clinic

…d the use and perceptions of cannabis and vaping in people with cystic fibrosis (CF) and CF transmembrane conductance regulator (CFTR)-related …

S69 Reduction in serum markers of inflammation in people with cystic fibrosis who are chronically infected with pseudomonas aeruginosa is seen after treatment with Elexacaftor/Tezacaftor/Ivacaftor

thoraxjnl · abstract · 2025-11-02 · 1 matching annotations

80.1%

Pseudomonas aeruginosa Pa CFTR CF Royal Brompton Hospital Elexacaftor

…c inflammation in people with (pw) CF chronically infected with Pseudomonas aeruginosa (Pa) after ≥6 months of the CFTR modulator, Elexacaftor/Tezacaf…